Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys
The cleanroom operates under stringent ISO Class 5 conditions, using ultrapure water and air systems
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
The new facility is expected to significantly improve access to high-quality medical services for patients across Gujarat and neighbouring regions
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
Subscribe To Our Newsletter & Stay Updated